Evidence map›Paper›PMID 32899726›Full record

ArticleNutrients2020

Chlorogenic Acid Potentiates the Anti-Inflammatory Activity of Curcumin in LPS-Stimulated THP-1 Cells.

Akshay Bisht, Martin Dickens, Kay Rutherfurd-Markwick, Rohith Thota, Anthony N Mutukumira, Harjinder Singh

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Extracellular Vesicles fromJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Chlorogenic acid suppresses angiogenesis in 4T1 breast tumorsResearch in pharmaceutical sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Frontiers in veterinary science · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Akshay BishtSchool of Food and Advanced Technology, College of Science, Massey University, Auckland 0745, New Zealand.ORCID 0000-0002-4500-8597
Martin DickensSchool of Health Sciences, College of Health, Massey University, Auckland 0745, New Zealand.
Kay Rutherfurd-MarkwickSchool of Health Sciences, College of Health, Massey University, Auckland 0745, New Zealand.
Rohith ThotaRiddet Research Institute, Massey University, Palmerston North 4442, New Zealand.ORCID 0000-0002-0293-913X
Anthony N MutukumiraSchool of Food and Advanced Technology, College of Science, Massey University, Auckland 0745, New Zealand.
Harjinder SinghRiddet Research Institute, Massey University, Palmerston North 4442, New Zealand.
Massey University · NZ

Funding

Riddet Research Institute, New Zealand. N/A
6 · The paper itself

Abstract

The anti-inflammatory effects of curcumin are well documented. However, the bioavailability of curcumin is a major barrier to its biological efficacy. Low-dose combination of complimentary bioactives appears to be an attractive strategy for limiting barriers to efficacy of bioactive compounds. In this study, the anti-inflammatory potential of curcumin in combination with chlorogenic acid (CGA), was investigated using human THP-1 macrophages stimulated with lipopolysaccharide (LPS). Curcumin alone suppressed TNF-α production in a dose-dependent manner with a decrease in cell viability at higher doses. Although treatment with CGA alone had no effect on TNF-α production, it however enhanced cell viability and co-administration with curcumin at a 1:1 ratio caused a synergistic reduction in TNF-α production with no impact on cell viability. Furthermore, an qRT-PCR analysis of NF-κB pathway components and inflammatory biomarkers indicated that CGA alone was not effective in reducing the mRNA expression of any of the tested inflammatory marker genes, except TLR-4. However, co-administration of CGA with curcumin, potentiated the anti-inflammatory effects of curcumin. Curcumin and CGA together reduced the mRNA expression of pro-inflammatory cytokines [TNF-α (~88%) and IL-6 (~99%)], and COX-2 (~92%), possibly by suppression of NF-κB (~78%), IκB-β-kinase (~60%) and TLR-4 receptor (~72%) at the mRNA level. Overall, co-administration with CGA improved the inflammation-lowering effects of curcumin in THP-1 cells.

Indexed as

Anti-Inflammatory AgentsBiological AvailabilityCell SurvivalChlorogenic AcidCurcuminCyclooxygenase 2Drug Therapy, CombinationHumansI-kappa B KinaseInflammationLipopolysaccharidesMacrophagesNF-kappa BRNA, MessengerSignal TransductionTHP-1 CellsAnti-Inflammatory AgentsChlorogenic AcidCurcuminCyclooxygenase 2I-kappa B KinaseLipopolysaccharidesNF-kappa BRNA, MessengerToll-Like Receptor 4Tumor Necrosis Factor-alphabioactive combinationchlorogenic acidcurcumininflammationNF-κB pathway

Identifiers

PMID32899726
PMCPMC7551420
OpenAlexW3083383004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.